Anil Suryaprasad, MD
Hospitalist · Jacksonville, FLNPI 1508083866
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.5% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Gilead at 33.4% of the total. Reporting peaked in 2022 at $2,152 and has fallen 98.7% since, to $27 in 2024. Among hospitalist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$1K
- Viiv Healthcare Company$1K
- Theratechnologies Inc.$489
- Merck$487
- Johnson & Johnson$351
- AbbVie$322
- plus $151 from 6 others
Across 1 payment — averaging $4500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$5K
What the payments were for
- Food & beverage$4,12693%
- Education$2897%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 71 | $1,475 |
| Viiv Healthcare Company | 72 | $1,141 |
| Theratechnologies Inc. | 17 | $489 |
| Merck | 25 | $487 |
| Johnson & Johnson(2 entities) | 24 | $351 |
| AbbVie | 17 | $322 |
| Novo Nordisk | 3 | $53 |
| Lilly USA, LLC | 2 | $25 |
| Amarin Pharma, Inc. | 1 | $21 |
| EMD Serono, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EGRIFTA SV$195
How this compares
$4,415 in reported general payments places this provider in the 95th percentile of 1,570 hospitalist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hospitalist in Jacksonville
- Carlos RojasJacksonville$6K
- Margaret WebbJacksonville$4K
- Jeffrey GarlandJacksonville$3K
- David ShupeJacksonville$3K
- Deepak ScindiaJacksonville$2K
- Murray EpsteinMiami$370K
- Oliver AbelaFort Myers$77K
- Joshua LenchusFort Lauderdale$73K
- Tuncay TaskesenThe Villages$22K
- Diego MunozApopka$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.